The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1309
Deep Brain Stimulation for Parkinson's Disease
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.

Deep brain stimulation (DBS) is increasingly used to treat advanced Parkinson's disease (PD), but few controlled clinical trials have been published. New evidence from a large controlled study has recently become available.

SURGICAL TREATMENT OF PARKINSON’S DISEASE — Medical therapy is effective for initial treatment of Parkinson's disease.1 Surgery should generally be reserved for patients with tremor that is refractory to medical treatment or for those with major dyskinesias or clinical fluctuations while on levodopa (Sinemet, and others). Surgery does not help patients who were unresponsive to levodopa. Appropriate candidates for surgery are those whose cognition is relatively intact on full neuropsychological testing.

DBS — Bilateral DBS of the subthalamic nucleus with continuous high-frequency electrical stimuli from electrodes implanted in the brain (connected ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Deep Brain Stimulation for Parkinson's Disease
Article code: 1309b
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian